GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
- Conditions
- GBS DiseaseStreptococcus Agalactiae
- Interventions
- Biological: PlaceboBiological: GBS trivalent vaccine
- First Posted Date
- 2014-01-27
- Last Posted Date
- 2020-12-29
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 75
- Registration Number
- NCT02046148
- Locations
- 🇺🇸
GSK Investigational Site, Nashville, Tennessee, United States
A Study to Assess the Systemic Exposure of FLIXOTIDE™ (Fluticasone Propionate) and SERETIDE™ (Fluticasone Propionate and Salmeterol) Given With VENTOLIN™ Mini-Spacer Compared to the Aerochamber Plus Spacer
- Conditions
- Asthma
- Interventions
- Device: VENTOLIN Mini-SpacerDevice: Aerochamber Plus spacer
- First Posted Date
- 2014-01-27
- Last Posted Date
- 2018-06-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 21
- Registration Number
- NCT02045953
- Locations
- 🇬🇧
GSK Investigational Site, London, United Kingdom
Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib
- Conditions
- Cancer
- Interventions
- Drug: GSK2110183 IR Tablet
- First Posted Date
- 2014-01-20
- Last Posted Date
- 2017-11-13
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 18
- Registration Number
- NCT02040480
- Locations
- 🇦🇺
GSK Investigational Site, Randwick, New South Wales, Australia
PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011
- First Posted Date
- 2014-01-20
- Last Posted Date
- 2016-08-05
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1
- Registration Number
- NCT02039960
A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer
- First Posted Date
- 2014-01-13
- Last Posted Date
- 2014-05-19
- Lead Sponsor
- GlaxoSmithKline
- Registration Number
- NCT02034097
Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung Carcinoma
- First Posted Date
- 2014-01-13
- Last Posted Date
- 2019-12-06
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 29
- Registration Number
- NCT02034123
- Locations
- 🇪🇸
GSK Investigational Site, Málaga, Spain
Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers
- Conditions
- Atrophy, Geographic
- Interventions
- Drug: GSK933776 for SQ administrationDrug: GSK933776 for IM administrationDrug: GSK933776 for IV administration
- First Posted Date
- 2014-01-13
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 36
- Registration Number
- NCT02033668
- Locations
- 🇺🇸
GSK Investigational Site, Overland Park, Kansas, United States
Post Marketing Surveillance for Contac Bien Z in Japan
- Conditions
- Allergic RhinitisSeasonal Allergic Rhinitis
- First Posted Date
- 2013-12-25
- Last Posted Date
- 2016-05-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1552
- Registration Number
- NCT02020902
- Locations
- 🇯🇵
Drug Store Seki, Saitama, Japan
A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis
- Conditions
- Churg-Strauss Syndrome
- Interventions
- Biological: MepolizumabDrug: Placebo
- First Posted Date
- 2013-12-25
- Last Posted Date
- 2018-01-31
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 136
- Registration Number
- NCT02020889
- Locations
- 🇬🇧
GSK Investigational Site, Portsmouth, United Kingdom
Study to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney Disease
- First Posted Date
- 2013-12-24
- Last Posted Date
- 2018-02-12
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 97
- Registration Number
- NCT02019719
- Locations
- 🇯🇵
GSK Investigational Site, Toyama, Japan